MedicineEurope PMC

Ranked by formulaVerdict: Notable

Advancing morphological profiling with self-supervised learning through comparative insights into representation learning of cellular perturbations

Self-supervised learning (SSL) enables scalable, label-free foundation models (FMs) that learn task-agnostic representations directly from images, bypassing cell segmentation and feature engineering inherent to…

By Abdelmoula, Albuquerque, Jaensch +6Nature methods

Score█████░░░░░5.0

Key numbers

  • 37% gains in site-averaged mean

VerdictWorth a reader's time today.

Read the original

Abstract

Self-supervised learning (SSL) enables scalable, label-free foundation models (FMs) that learn task-agnostic representations directly from images, bypassing cell segmentation and feature engineering inherent to classical morphological profiling. We present a large-scale evaluation of SSL FMs for image-based phenotypic profiling, covering contrastive (DINO), masked-based generative (MAE, iTPN) and hybrid (DINOv2) learning mechanisms, pretrained on all unannotated chemical perturbations from the Joint Undertaking for Morphological Profiling-Cell Painting (JUMP-CP) dataset (119,876 compounds, ~1.77 million images, 7 laboratories). Here we show that top-performing SSL models outperformed CellProfiler in compound-replicate retrieval on the held-out JUMP-Target2 set (302 annotated compounds, P ≤ 0.001). DINO and DINOv2 generalized across diverse perturbations and cell types, outperforming CellProfiler with 31-37% gains in site-averaged mean average precision for mechanism-of-action retrieval on EU-OPENSCREEN Bioactives (2,464 compounds), and consistently surpassing masked-based models across all benchmarks. This study provides a systematic assessment of SSL approaches for advancing morphological profiling and offers pretrained FMs to accelerate drug discovery.

Walid M Abdelmoula, Tomé Albuquerque, Steffen Jaensch, Pushpak Pati, Michiel Van Dyck, Samantha J Allen, Litao Zhang, Tommaso Mansi, Rui Liao

The editor's rubric

Heuristic review

Leverage4 / 5
A general-purpose tool used across several fields (Adam, ResNet, LoRA, next-generation sequencing).
10% of this desk’s rubric
Magnitude3 / 5
Large gain: roughly 2x, or a clear new state of the art on a hard, unsaturated problem.
20% of this desk’s rubric
Evidence4 / 5
Strong: large scale, preregistered, independently replicated, or a well-powered randomized trial.
32% of this desk’s rubric
Novelty3 / 5
A genuinely new approach to an open problem.
8% of this desk’s rubric
Trajectory3 / 5
A clear path to scale.
5% of this desk’s rubric
Stakes2 / 5
Benefits a professional community (practitioners, clinicians, engineers).
25% of this desk’s rubric

Editor’s rationale

Heuristic triage from title and abstract text only, not a reading of the paper. Cues found: method (we propose, we report); breadth (general-purpose, generalizes); gains (outperforms); novelty (discovery); verification (p-value, error bars, held-out test); scale (scalable); stakes (global scale).

How the score was computed

rank-2026-10-18

Score█████░░░░░5.0

Score = 10 × (80% × adjusted merit / 10 + 10% × attention + 10% × freshness)

Desks place stronger verdicts first, then use this score to order work within the same verdict.

Merit
6.3 / 10
Weighted rubric, evidence-gated.
Adjusted merit
5.2 / 10
Shrunk toward the desk prior by editor confidence (50%).
Attention
0%
Citations, upvotes, points, mentions.
Freshness
85%
Half-life decay since publication.
  • Citations0 (reference 20, via openalex, Oct 31, 2026, 05:48 UTC)

The record

  • Reviewed by heuristic-v10 on Oct 31, 2026, 06:17 UTC. Paper type: method.
  • Categories: Journal Article
  • TOP, No.4 in the Front page edition of October 31, 2026.
  • TOP, No.1 in the Biology edition of October 31, 2026.